Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Milano

Showing results (171-180 of 347) with videos related to

Pageof 35
Sort By:
European Journal of Cancer (Oxford, England : 1990)|March 1, 1996
Pharmacokinetics and pharmacodynamics of nitrosourea fotemustine: a French cancer centre multicentric studyA Iliadis, M C Launay-Iliadis, C Lucas, et al.
British Journal of Cancer|June 26, 2008
Combined effects of bevacizumab with erlotinib and irradiation: a preclinical study on a head and neck cancer orthotopic modelA Bozec, A Sudaka, J-L Fischel, et al.
European Journal of Cancer (Oxford, England : 1990)|March 31, 2000
A limited sampling strategy for determining carboplatin AUC and monitoring drug dosageE Chatelut, X Pivot, J Otto, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
A role for dihydropyrimidine dehydrogenase and thymidylate synthase in tumour sensitivity to fluorouracilA Beck, M C Etienne, S Chéradame, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Importance of the irradiation timing within a chemoradiotherapy sequence including cisplatin and 5-FU-folinic acid. Experimental resultsJ L Lagrange, J L Fischel, S Galliani, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Sequence-dependent cytotoxic effects of the combination of a new nitrosourea, fotemustine, with 5-fluorouracil plus folinic acidJ L Fischel, P Formento, M Berlion, et al.
Journal of Materials Science. Materials in Medicine|May 29, 2014
Bone substitutes in orthopaedic surgery: from basic science to clinical practiceV Campana, G Milano, E Pagano, et al.
Anti-Cancer Drugs|July 8, 2000
Time-schedule dependency of S 16020, a new topoisomerase II inhibitorJ Soudon, G Milano, M G Poullain, et al.
Revue De Stomatologie Et De Chirurgie Maxillo-Faciale|September 2, 2008
[Study of aberrant methylation of TSG in saliva in case of upper-aerodigestive-tract cancer]C A Righini, F de Fraipont, J-F Timsit, et al.
Anales Espanoles De Pediatria|September 27, 2000
[Admissions of patients with AIDS to pediatric intensive care units]M Casanova Román, J Ríos Hurtado, F J García Martín, et al.
Pageof 35

Showing results (171-180 of 347) with videos related to

Sort By:
Pageof 35
European Journal of Cancer (Oxford, England : 1990)|March 1, 1996
Pharmacokinetics and pharmacodynamics of nitrosourea fotemustine: a French cancer centre multicentric studyA Iliadis, M C Launay-Iliadis, C Lucas, et al.
British Journal of Cancer|June 26, 2008
Combined effects of bevacizumab with erlotinib and irradiation: a preclinical study on a head and neck cancer orthotopic modelA Bozec, A Sudaka, J-L Fischel, et al.
European Journal of Cancer (Oxford, England : 1990)|March 31, 2000
A limited sampling strategy for determining carboplatin AUC and monitoring drug dosageE Chatelut, X Pivot, J Otto, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
A role for dihydropyrimidine dehydrogenase and thymidylate synthase in tumour sensitivity to fluorouracilA Beck, M C Etienne, S Chéradame, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Importance of the irradiation timing within a chemoradiotherapy sequence including cisplatin and 5-FU-folinic acid. Experimental resultsJ L Lagrange, J L Fischel, S Galliani, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Sequence-dependent cytotoxic effects of the combination of a new nitrosourea, fotemustine, with 5-fluorouracil plus folinic acidJ L Fischel, P Formento, M Berlion, et al.
Journal of Materials Science. Materials in Medicine|May 29, 2014
Bone substitutes in orthopaedic surgery: from basic science to clinical practiceV Campana, G Milano, E Pagano, et al.
Anti-Cancer Drugs|July 8, 2000
Time-schedule dependency of S 16020, a new topoisomerase II inhibitorJ Soudon, G Milano, M G Poullain, et al.
Revue De Stomatologie Et De Chirurgie Maxillo-Faciale|September 2, 2008
[Study of aberrant methylation of TSG in saliva in case of upper-aerodigestive-tract cancer]C A Righini, F de Fraipont, J-F Timsit, et al.
Anales Espanoles De Pediatria|September 27, 2000
[Admissions of patients with AIDS to pediatric intensive care units]M Casanova Román, J Ríos Hurtado, F J García Martín, et al.
Pageof 35